News

The U.S. Food and Drug Administration (FDA) has set Feb. 1, 2025, as a goal date for deciding whether to approve SPN-830, an apomorphine infusion pump, for the continuous treatment of off episodes in Parkinson’s disease. That’s according to a financial update from the device’s developer,…

The Cleveland Clinic’s Center for Neurological Restoration, which specializes in medical and surgical approaches for treating Parkinson’s disease and other neurological and movement disorders, has once again been recognized as a Center of Excellence by the Parkinson’s Foundation. It was previously awarded the designation in 2018. That designation…

Delphi-MD, a system that measures brain activity, may be used for the early diagnosis of Parkinson’s disease and for differentiating between its subtypes, particularly those marked by rapid disease progression, a study shows. The technology, developed by Quantalx Neuroscience, provides direct, real-time imaging of the brain’s electrical…

A researcher at the University of Rhode Island has received nearly $500,000 in federal funding to investigate the neuronal changes underlying visual hallucinations — seeing something that is not real — in people with Parkinson’s disease. The funding, from the National Science Foundation, was granted to Yalda Shahriari, PhD,…

SandboxAQ has signed a $25 million research grant through an initiative of The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to develop new treatments that target the LRRK2 gene, mutations in which are one of the most common genetic causes of Parkinson’s disease. Under the partnership, which…

People with Parkinson’s disease who live in areas with measurable air pollution are at a heightened risk of hospitalization, according to a new analysis in the U.S. This work “provides critical information on whether air pollution could be used as a lever to reduce the risk of hospitalizations” with…

Analyzing vocal recordings could help in detecting Parkinson’s disease at early stages, according to a study that tested the idea using decades’ worth of recordings from celebrities who went on to develop the neurodegenerative condition. “This study shows that early patterns of [speech changes] are detectable up to 10…

Among adults in the U.K., poor hand grip strength is associated with an increased risk of developing Parkinson’s disease, especially among those who also have genetic risk factors for the neurodegenerative condition, according to a new report. Indeed, “compared with those with high [grip strength], low-[grip strength] individuals had…

Besides motor challenges, people with Parkinson’s disease have difficulty with motor imagery, or generating a mental representation of a movement, a study showed. That’s particularly true for the more affected side of the body. “Even when people with Parkinson’s think about movement, it’s different for their more affected side,”…

Metabolic syndrome, a cluster of conditions that can increase the risk of heart disease, diabetes, and stroke, is associated with a higher risk of developing dementia in people with Parkinson’s disease, according to recent research. “These findings advocate for comprehensive management of MetS [metabolic syndrome] as a pivotal strategy…